Exec Dir Early Pipeline Commercialization

 

At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where 'Health for all Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us, expanding our thinking, growing our capabilities and redefining ‘impossible’. There are so many reasons to join us. If you’re hungry to build a varied and meaningful career in a community of brilliant and diverse minds to make a real difference, there’s only one choice.

 

Exec Dir Early Pipeline Commercialization 

 

Bayer is seeking a strategic, commercially driven leader to join the organization as Executive Director, Oncology Pipeline Commercial Strategy Lead. This role will lead commercial strategy development across Bayer’s oncology pipeline, spanning early-, mid-, and late-stage assets. The successful candidate will help shape differentiated asset strategies, inform portfolio choices, and strengthen launch readiness to support Bayer’s long-term oncology growth ambitions. This leader will bring deep oncology expertise, strong executive presence, and the ability to influence effectively across a complex, matrixed environment.

 

YOUR TASKS AND RESPONSIBILITIES

 

The primary responsibilities of this role, Executive Director Early Pipeline Commercialization are to: 

 

• Lead the development of integrated commercial strategies for oncology pipeline assets across early, mid, and late stages of development. Lead commercial assessment of partnering opportunities;
• Provide strategic commercial input on disease area opportunity, competitive landscape, unmet need, treatment paradigm evolution, patient journey, and market access considerations;
• Partner closely with R&D, BD&L medical affairs, market access, finance, business development, and regional and local commercial teams to shape development and commercialization plans;
• Inform key governance decisions through robust commercial assessments, including indication prioritization, lifecycle strategy, portfolio trade-offs, and investment decisions;
• Define target product profiles, strategic positioning, segmentation approaches, and value proposition frameworks for pipeline assets;
• Guide insight generation, market research, forecasting assumptions, scenario planning, and opportunity sizing;
• Ensure commercial perspectives are embedded in milestone decisions from early development through pre-launch planning;
• Support development of launch strategies and launch readiness plans, including market shaping, stakeholder engagement, access strategy, and organizational preparedness;
• Drive portfolio prioritization discussions by evaluating commercial attractiveness, strategic fit, competitive intensity, and execution feasibility;
• Identify strategic risks and opportunities and recommend actions to optimize future asset value.

 

Leadership Expectations

 

• Serve as a senior strategic leader and trusted commercial thought partner within Bayer’s organization;
• Influence stakeholders across a global matrix through strong strategic reasoning, communication, and sound judgment;
• Lead with a patient-centered, science-informed, and performance-oriented mindset;
• Create alignment across diverse functions and regions while navigating ambiguity and competing priorities;
• Promote high-quality analysis, disciplined decision-making, and strong execution focus;
• Model VACC leadership principles (Visionary, Architect, Catalyst, Coach).

 

Therapeutic Area Expertise

 

The ideal candidate will bring strong oncology therapeutic area expertise, including a demonstrated understanding of:

• Oncology treatment paradigms and evolving standards of care;
• Biomarker-driven and precision medicine approaches;
• Solid tumors market dynamics;;
• Clinical development and commercialization considerations across the oncology lifecycle
• Stakeholder needs across providers, patients, payers, and health systems;;
• Competitive intelligence and market access dynamics relevant to oncology

 

Working relations: Global

 

• Global commercial